521 related articles for article (PubMed ID: 29572291)
1. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
Park JK; Lee YJ; Shin K; Ha YJ; Lee EY; Song YW; Choi Y; Winthrop KL; Lee EB
Ann Rheum Dis; 2018 Jun; 77(6):898-904. PubMed ID: 29572291
[TBL] [Abstract][Full Text] [Related]
2. Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
Park JK; Lee MA; Lee EY; Song YW; Choi Y; Winthrop KL; Lee EB
Ann Rheum Dis; 2017 Sep; 76(9):1559-1565. PubMed ID: 28468794
[TBL] [Abstract][Full Text] [Related]
3. A Multicenter, Prospective, Randomized, Parallel-Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis.
Park JK; Lee YJ; Shin K; Kang EH; Ha YJ; Park JW; Kim MJ; Kim MH; Choi SR; Jung Y; Lee JH; In Jung J; Kim JY; Winthrop KL; Lee EB
Arthritis Rheumatol; 2023 Feb; 75(2):171-177. PubMed ID: 35930728
[TBL] [Abstract][Full Text] [Related]
4. Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis.
Jain VK; Bhashini N; Balajee LK; Sistla S; Parija SC; Negi VS
Indian J Med Res; 2017 Apr; 145(4):464-470. PubMed ID: 28862177
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
Kapetanovic MC; Saxne T; Nilsson JA; Geborek P
Rheumatology (Oxford); 2007 Apr; 46(4):608-11. PubMed ID: 17114801
[TBL] [Abstract][Full Text] [Related]
6. Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis.
Mori S; Ueki Y; Hirakata N; Oribe M; Hidaka T; Oishi K
Ann Rheum Dis; 2012 Dec; 71(12):2006-10. PubMed ID: 22887851
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
Subesinghe S; Bechman K; Rutherford AI; Goldblatt D; Galloway JB
J Rheumatol; 2018 Jun; 45(6):733-744. PubMed ID: 29545454
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-term methotrexate discontinuation on rheumatoid arthritis disease activity: post-hoc analysis of two randomized trials.
Park JK; Kim MJ; Choi Y; Winthrop K; Song YW; Lee EB
Clin Rheumatol; 2020 Feb; 39(2):375-379. PubMed ID: 31823141
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
Oren S; Mandelboim M; Braun-Moscovici Y; Paran D; Ablin J; Litinsky I; Comaneshter D; Levartovsky D; Mendelson E; Azar R; Wigler I; Balbir-Gurman A; Caspi D; Elkayam O
Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
[TBL] [Abstract][Full Text] [Related]
10. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
Ribeiro AC; Guedes LK; Moraes JC; Saad CG; Aikawa NE; Calich AL; França IL; Carvalho JF; Sampaio-Barros PD; Goncalves CR; Borba EF; Timenetsky Mdo C; Precioso AR; Duarte A; Bonfa E; Laurindo IM
Ann Rheum Dis; 2011 Dec; 70(12):2144-7. PubMed ID: 21859696
[TBL] [Abstract][Full Text] [Related]
11. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
van Assen S; Holvast A; Benne CA; Posthumus MD; van Leeuwen MA; Voskuyl AE; Blom M; Risselada AP; de Haan A; Westra J; Kallenberg CG; Bijl M
Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
[TBL] [Abstract][Full Text] [Related]
12. Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.
Park JK; Choi Y; Winthrop KL; Song YW; Lee EB
Ann Rheum Dis; 2019 Sep; 78(9):1283-1284. PubMed ID: 30904830
[No Abstract] [Full Text] [Related]
13. The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis.
Winthrop KL; Silverfield J; Racewicz A; Neal J; Lee EB; Hrycaj P; Gomez-Reino J; Soma K; Mebus C; Wilkinson B; Hodge J; Fan H; Wang T; Bingham CO
Ann Rheum Dis; 2016 Apr; 75(4):687-95. PubMed ID: 25795907
[TBL] [Abstract][Full Text] [Related]
14. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Kapetanovic MC; Kristensen LE; Saxne T; Aktas T; Mörner A; Geborek P
Arthritis Res Ther; 2014 Jan; 16(1):R2. PubMed ID: 24383620
[TBL] [Abstract][Full Text] [Related]
15. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
van de Witte S; Nauta J; Montomoli E; Weckx J
Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
[TBL] [Abstract][Full Text] [Related]
18. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.
Westra J; van Assen S; Wilting KR; Land J; Horst G; de Haan A; Bijl M
Clin Exp Immunol; 2014 Oct; 178(1):40-7. PubMed ID: 24889761
[TBL] [Abstract][Full Text] [Related]
19. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
